P&G to Challenge Ban on Vicks Action 500 Extra

Mumbai: US consumer health group Procter & Gamble's Indian business plans to challenge a government ban on its cough-and-cold medicine Vicks Action 500 Extra, citing potential health risks. Procter & Gamble Hygiene and Health Care said that while it had stopped selling the product, it was evaluating all options to challenge the ban. Vicks Action 500 Extra is a fixed-dose combination of paracetamol, phenylephrine and caffeine, which...